• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Teva to buy Allergan's generic business


<



Sorry to those of you who are original Allergan employees. No enhanced severance package for you. Only employees from the generic business will be effected by this next round of layoffs. .....